| |
SINGAPORE: Singapore's Health Sciences Authority (HSA) has signed a Memorandum of Understanding with its UK counterpart, the Medicines and Healthcare Products Regulatory Agency (MHRA).
The main objective of the MOU is to enhance the policy and regulatory frameworks for medicines and medical devices as well as to improve the safety and quality of such products marketed in each country.
This comes within a month of the MOU that HSA signed with Sweden's Medical Products Agency.
- CNA/yt
|
